Your browser doesn't support javascript.
loading
Increasing bowel cancer screening using SMS in general practice: the SMARTscreen cluster randomised trial.
McIntosh, Jennifer G; Jenkins, Mark; Wood, Anna; Chondros, Patty; Campbell, Tina; Wenkart, Edweana; O'Reilly, Clare; Dixon, Ian; Toner, Julie; Martinez-Gutierrez, Javiera; Govan, Linda; Emery, Jon D.
Afiliação
  • McIntosh JG; Centre for Epidemiology and Biostatistics, University of Melbourne, Melbourne.
  • Jenkins M; Centre for Epidemiology and Biostatistics, University of Melbourne, Melbourne.
  • Wood A; Department of General Practice and Primary Care, University of Melbourne, Melbourne.
  • Chondros P; Department of General Practice and Primary Care, University of Melbourne, Melbourne.
  • Campbell T; Healthily Pty Ltd, Melbourne.
  • Wenkart E; Pen Computer Systems, Sydney.
  • O'Reilly C; Workforce Development, Screening Early Detection and Immunisation, Cancer Council Victoria, Melbourne, and executive manager, Chronic Health, Population Health Unit, VACCHO, Melbourne.
  • Dixon I; Melbourne.
  • Toner J; Melbourne.
  • Martinez-Gutierrez J; Department of General Practice and Primary Care, University of Melbourne, Melbourne.
  • Govan L; Ballarat Goldfields/Wimmera Grampians, Western Victoria Primary Health Network, Ballarat.
  • Emery JD; Department of General Practice and Primary Care, University of Melbourne, Melbourne.
Br J Gen Pract ; 74(741): e275-e282, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38164588
ABSTRACT

BACKGROUND:

Australia has one of the highest incidences of colorectal cancer (CRC) worldwide. The Australian National Bowel Cancer Screening Program (NBCSP) is a best-practice, organised screening programme, but uptake is low (40.9%) and increasing participation could reduce morbidity and mortality associated with CRC. Endorsement by GPs is strongly associated with increasing screening uptake.

AIM:

This study (SMARTscreen) aimed to test whether a multi-intervention short message service (SMS) sent by general practices to 50-60-year-old patients who were due to receive the NBCSP kit would increase NBCSP uptake, by comparing it with usual care. DESIGN AND

SETTING:

A stratified cluster randomised controlled trial was undertaken, involving 21 Australian general practices in Western Victoria, Australia.

METHOD:

For intervention practices, people due to receive the NBCSP kit within a 6-month study period were sent an SMS just before receiving the kit. The SMS included a personalised message from the person's general practice endorsing the kit, a motivational narrative video, an instructional video, and a link to more information. Control practices continued with usual care, comprising at-home testing with a faecal immunochemical test (FIT) through the NBCSP. The primary outcome was the between-arm percentage difference in uptake of FIT screening within 12 months from randomisation, which was estimated using generalised linear model regression.

RESULTS:

In total, 39.2% (1143/2914) of people in 11 intervention practices and 23.0% (583/2537) of people in 10 control practices had a FIT result in their electronic health records - a difference of 16.5% (95% confidence interval = 2.02 to 30.9).

CONCLUSION:

The SMS intervention increased NBCSP kit return in 50-60-year-old patients in general practice. This finding informed a larger trial - SMARTERscreen - to test this intervention in a broader Australian population.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Medicina Geral Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Medicina Geral Idioma: En Ano de publicação: 2024 Tipo de documento: Article